Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?
To access this article, please choose from the options below
PII: S0145-2126(02)00219-9
© 2002 Elsevier Science Ltd. All rights reserved.
PII: S0145-2126(02)00219-9
© 2002 Elsevier Science Ltd. All rights reserved.